Cargando…

Transforming growth factor β-induced epithelial-to-mesenchymal signature predicts metastasis-free survival in non-small cell lung cancer

Transforming growth factor beta (TGFβ) plays a key role in regulating epithelial-to-mesenchymal transition (EMT). A gene expression signature (TGFβ-EMT) associated with TGFβ-induced EMT activities was developed using human Non-Small Cell Lung Carcinoma (NSCLC) cells treated with TGFβ-1 and subjected...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gordian, Edna, Welsh, Eric A., Gimbrone, Nicholas, Siegel, Erin M., Shibata, David, Creelan, Ben C., Cress, William Douglas, Eschrich, Steven A., Haura, Eric B., Muñoz-Antonia, Teresita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368226/ https://www.ncbi.nlm.nih.gov/pubmed/30783512 http://dx.doi.org/10.18632/oncotarget.26574

Ejemplares similares

Correction: Transforming growth factor β-induced epithelial-to-mesenchymal signature predicts metastasis-free survival in non-small cell lung cancer
por: Gordian, Edna, et al.
Publicado: (2021)

Transforming Growth Factor β Signaling Overcomes Dasatinib Resistance in Lung Cancer
por: Gordian, Edna, et al.
Publicado: (2014)

Translating Hispanic Genomic Factors in Lung Cancer Into Clinical Practice: EGFR Testing for Improved Outcomes
por: Hudson, Janella, et al.
Publicado: (2016)

Characterization of epidermal growth factor receptor (EGFR) P848L, an unusual EGFR variant present in lung cancer patients, in a murine Ba/F3 model
por: Sarcar, Bhaswati, et al.
Publicado: (2019)

Early2 factor (E2F) deregulation is a prognostic and predictive biomarker in lung adenocarcinoma
por: Chen, Lu, et al.
Publicado: (2016)

CDK4/6 inhibition synergizes with inhibition of P21-Activated Kinases (PAKs) in lung cancer cell lines
por: Wright, Gabriela M., et al.
Publicado: (2021)

Differential association of STK11 and TP53 with KRAS mutation-associated gene expression, proliferation and immune surveillance in lung adenocarcinoma
por: Schabath, Matthew B., et al.
Publicado: (2015)

Trim28 Contributes to EMT via Regulation of E-Cadherin and N-Cadherin in Lung Cancer Cell Lines
por: Chen, Lu, et al.
Publicado: (2014)

Characteristics and Validation Techniques for PCA-Based Gene-Expression Signatures
por: Berglund, Anders E., et al.
Publicado: (2017)

Hyper-phosphorylation of Rb S249 together with CDK5R2/p39 overexpression are associated with impaired cell adhesion and epithelial-to-mesenchymal transition: Implications as a potential lung cancer grading and staging biomarker
por: Pérez-Morales, Jaileene, et al.
Publicado: (2018)

Phase 1 trial of dasatinib combined with afatinib for epidermal growth factor receptor- (EGFR-) mutated lung cancer with acquired tyrosine kinase inhibitor (TKI) resistance
por: Creelan, Ben C., et al.
Publicado: (2019)

Epithelial-Mesenchymal Transition and Metastasis under the Control of Transforming Growth Factor β
por: Tsubakihara, Yutaro, et al.
Publicado: (2018)

Surface tension of model tissues during malignant transformation and epithelial–mesenchymal transition
por: Nagle, Irène, et al.
Publicado: (2022)

Epithelial-Mesenchymal Transition with Malignant Transformation Leading Multiple Metastasis from Disseminated Peritoneal Leiomyomatosis
por: Chiu, Hsiao-Chen, et al.
Publicado: (2018)

Arecoline induces epithelial‐mesenchymal transformation and promotes metastasis of oral cancer by SAA1 expression
por: Ren, Hui, et al.
Publicado: (2021)

Evaluating somatic tumor mutation detection without matched normal samples
por: Teer, Jamie K., et al.
Publicado: (2017)

Strategies for power calculations in predictive biomarker studies in survival data
por: Chen, Dung-Tsa, et al.
Publicado: (2016)

Metastasis Related Epithelial-Mesenchymal Transition Signature Predicts Prognosis and Response to Immunotherapy in Gastric Cancer
por: Song, Junquan, et al.
Publicado: (2022)

GMSimpute: a generalized two-step Lasso approach to impute missing values in label-free mass spectrum analysis
por: Li, Qian, et al.
Publicado: (2020)

ZEB1 Mediates Acquired Resistance to the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer
por: Yoshida, Takeshi, et al.
Publicado: (2016)

Epithelial–mesenchymal plasticity in carcinoma metastasis
por: Tsai, Jeff H., et al.
Publicado: (2013)

Epithelial–mesenchymal transition in tumor metastasis
por: Yeung, Kay T., et al.
Publicado: (2016)

Activity-Based Proteomics Reveals Heterogeneous Kinome and ATP-Binding Proteome Responses to MEK Inhibition in KRAS Mutant Lung Cancer
por: Kim, Jae-Young, et al.
Publicado: (2016)

Histone Deacetylase Inhibitors Downregulate Checkpoint Kinase 1 Expression to Induce Cell Death in Non-Small Cell Lung Cancer Cells
por: Brazelle, William, et al.
Publicado: (2010)

Ahnak promotes tumor metastasis through transforming growth factor-β-mediated epithelial-mesenchymal transition
por: Sohn, Mira, et al.
Publicado: (2018)

Diverting epithelial-to-mesenchymal transition to transform cancer cells to adipocytes: A promising strategy to stop metastasis
por: Dalamaga, Maria, et al.
Publicado: (2019)

Superior breast cancer metastasis risk stratification using an epithelial-mesenchymal-amoeboid transition gene signature
por: Emad, Amin, et al.
Publicado: (2020)

Gene co-expression and histone modification signatures are associated with melanoma progression, epithelial-to-mesenchymal transition, and metastasis
por: Azevedo, Hátylas, et al.
Publicado: (2020)

Metastasis Related Epithelial-Mesenchymal Transition Signature Predicts Prognosis and Response to Chemotherapy in Acute Myeloid Leukemia
por: Qu, Shuang, et al.
Publicado: (2023)

A Pilot Proteogenomic Study with Data Integration Identifies MCT1 and GLUT1 as Prognostic Markers in Lung Adenocarcinoma
por: Stewart, Paul A., et al.
Publicado: (2015)

Integrins and Epithelial-Mesenchymal Cooperation in the Tumor Microenvironment of Muscle-Invasive Lethal Cancers
por: Harryman, William L., et al.
Publicado: (2022)

miR-186 regulates epithelial–mesenchymal transformation to promote nasopharyngeal carcinoma metastasis by targeting ZEB1()
por: Tang, Liangke, et al.
Publicado: (2023)

A Six-Epithelial–Mesenchymal Transition Gene Signature May Predict Metastasis of Triple-Negative Breast Cancer
por: Wei, Li Yuan, et al.
Publicado: (2020)

Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis
por: Jolly, Mohit Kumar, et al.
Publicado: (2015)

Flotillin-2 promotes nasopharyngeal carcinoma metastasis and is necessary for the epithelial-mesenchymal transition induced by transforming growth factor-β
por: Zhao, Liang, et al.
Publicado: (2015)

Characterizing Tyrosine Phosphorylation Signaling in Lung Cancer Using SH2 Profiling
por: Machida, Kazuya, et al.
Publicado: (2010)

Nicotine Promotes Tumor Growth and Metastasis in Mouse Models of Lung Cancer
por: Davis, Rebecca, et al.
Publicado: (2009)

A community‐based lung cancer rapid tissue donation protocol provides high‐quality drug‐resistant specimens for proteogenomic analyses
por: Boyle, Theresa A., et al.
Publicado: (2019)

Epithelial-mesenchymal transition in breast cancer progression and metastasis
por: Wang, Yifan, et al.
Publicado: (2011)

Contribution of epithelial-mesenchymal transitions to organogenesis and cancer metastasis
por: Campbell, Kyra
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_tachb09niqit77tq1t77ohk81p